The results of Mo et al.’s study on newly diagnosed T2D patients showed that intake of ACB in this group for 1 year decreased TNF-α levels, but these changes were not significant compared with the group intake of metformin (127). This evidence concerns the gene TNF and type 2 diabetes mellitus.